Legacy CG’s Abbott ABT Stock Holding History

Legacy CG’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-110	Closed	-$12K	–	49
2022 Q2	$12K	Buy	+110	New	+$12.5K	0.01%	93
2022 Q1	–	Sell	-22,144	Closed	-$3.12M	–	49
2021 Q4	$3.12M	Buy	+22,144	New	+$2.83M	1.88%	25

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Legacy CG's ABT Position: Q3 2022 in Review

Legacy CG sold out of Abbott (ABT) in Q3 2022, closing a stake of 110 shares — an estimated $12K sold.

Legacy CG first reported a position in ABT in Q4 2021 and held it in 2 quarters. The position peaked at $3.12M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold ABT as of Q3 2022.

Legacy CG reported no remaining Abbott position as of Q3 2022 after selling out during the quarter.
Legacy CG sold 110 Abbott shares in Q3 2022, an estimated $12K.
Legacy CG first reported a position in Abbott in Q4 2021 and held it in 2 quarters.
Legacy CG's Abbott position peaked at $3.12M in Q4 2021.
2,620 funds tracked by Wall St. Rank held Abbott as of Q3 2022.

Based on Legacy CG's 13F filing for Q3 2022, filed 4 Nov 2022.